Recibo’s shingles vaccine shows positive safety profile in Phase I trial

Recibo’s shingles vaccine shows positive safety profile in Phase I trial

Submitted by admin on January 2, 2024 - 9:48am
Source: 
Clinical Trials Arena
News Tags: 
Recbio
China
clinical trials
vaccines
shingles
Headline: 
Recibo’s shingles vaccine shows positive safety profile in Phase I trial
snippet: 

Jiangsu Recbio Technology will also run a Phase I trial in 180 healthy adult subjects aged 40 years and above in China.

Do Not Allow Advertisers to Use My Personal information